|Articles|June 1, 2001
- Pharmaceutical Executive-06-01-2001
- Volume 0
- Issue 0
Relocation: Coming to America
Author(s)Kevin Gopal
Berlin, Germany-Putting the US market at the heart of its bid to maintain double-digit growth, last month Schering began to relocate its therapeutics headquarters to an existing facility in Montville, New Jersey.
Advertisement
Articles in this issue
almost 25 years ago
Industry Under Investigationalmost 25 years ago
Emotion - The New Brand Integratoralmost 25 years ago
For Love of the Gamealmost 25 years ago
Field of Dreamsalmost 25 years ago
Workshop: Access Optionsalmost 25 years ago
Emotion - The New Brand Integratoralmost 25 years ago
Rx-to-OTC: Unwanted Attentionalmost 25 years ago
Emotion - Biotech Renaissance Manalmost 25 years ago
Stocks: Catching the Market Bluesalmost 25 years ago
Gathering LightAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Does FDA's Shift From Two Pivotal Trials to One Represent a Genuine Evolution?
2
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
3
Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson & Johnson Enters Collaboration with Department of Health - Abu Dhabi
4
Pharmaceutical Executive Daily: FDA Approves Datroway
5